Adial Pharmaceuticals (ADIL) Institutional Ownership

$1.70
-0.20 (-10.53%)
(As of 04/23/2024 ET)

Institutional Ownership Changes (13F Filings) for Adial Pharmaceuticals (NASDAQ:ADIL)

Current
Institutional Ownership
Percentage
16.41%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$10.82M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$3.21M
Get ADIL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adial Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ADIL Institutional Buying and Selling by Quarter

Adial Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2024Armistice Capital LLC159,000$296K0.0%N/A9.578%
11/9/2023Manchester Capital Management LLC48,097$134K0.0%-96.0%3.942%
5/9/2023Manchester Capital Management LLC1,202,452$421K0.1%N/A4.216%
11/7/2022Virtu Financial LLC77,694$27K0.0%+142.7%0.301%
8/2/2022Thompson Davis & CO. Inc.21,000$28K0.0%N/A0.088%
7/22/2022Truist Financial Corp33,862$45K0.0%N/A0.142%
7/13/2022Private Advisor Group LLC21,400$29K0.0%-37.3%0.090%
11/12/2021Oppenheimer & Co. Inc.38,500$165K0.0%+37.5%0.190%
11/12/2021NorthRock Partners LLC10,000$43K0.0%N/A0.049%
10/29/2021Commonwealth Equity Services LLC36,461$156K0.0%+25.5%0.180%
9/17/2021Virtu Financial LLC31,038$79K0.0%N/A0.153%
8/16/2021State Street Corp48,954$125K0.0%N/A0.260%
8/13/2021Northern Trust Corp21,873$56K0.0%N/A0.116%
8/13/2021Geode Capital Management LLC88,246$225K0.0%+13.2%0.469%
8/13/2021Vanguard Group Inc.585,035$1.49M0.0%+172.4%3.112%
8/11/2021Commonwealth Equity Services LLC29,050$74K0.0%+31.7%0.155%
8/3/2021Oppenheimer & Co. Inc.28,000$71K0.0%+93.1%0.152%
7/17/2021Golden Green Inc.24,700$63K0.0%N/A0.134%
5/14/2021Dimensional Fund Advisors LP31,410$76K0.0%+68.8%0.179%
5/13/2021Barclays PLC15,850$38K0.0%N/A0.091%
5/12/2021Rede Wealth LLC15,000$36K0.0%N/A0.086%
5/10/2021Oppenheimer & Co. Inc.14,500$35K0.0%N/A0.083%
5/4/2021Commonwealth Equity Services LLC22,050$53K0.0%+107.3%0.126%
4/22/2021Private Advisor Group LLC36,650$89K0.0%N/A0.212%
3/8/2021Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129%
2/25/2021Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129%
2/10/2021Renaissance Technologies LLC98,900$168K0.0%+6.5%0.687%
12/11/2020Virtu Financial LLC18,902$42K0.0%N/A0.131%
8/14/2020Bank of America Corp DE150,000$209K0.0%N/A1.115%
(Data available from 1/1/2016 forward)

ADIL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ADIL shares?

During the previous two years, the following institutional investors and hedge funds held shares of Adial Pharmaceuticals shares: Armistice Capital LLC ($296K), Manchester Capital Management LLC ($134K), Truist Financial Corp ($45K), Private Advisor Group LLC ($29K), and Thompson Davis & CO. Inc. ($28K), Virtu Financial LLC ($27K).Learn more on ADIL's institutional investors.

What percentage of Adial Pharmaceuticals stock is owned by institutional investors?

16.41% of Adial Pharmaceuticals stock is owned by institutional investors. Learn more on ADIL's institutional investor holdings.

Which institutional investors have been buying Adial Pharmaceuticals stock?

The following institutional investors have purchased Adial Pharmaceuticals stock in the last 24 months: Manchester Capital Management LLC ($1.20M), Armistice Capital LLC ($159K), Virtu Financial LLC ($45.68K), Truist Financial Corp ($33.86K), and Thompson Davis & CO. Inc. ($21K).

How much institutional buying is happening at Adial Pharmaceuticals?

Institutional investors have bought a total of 1,461,995 shares in the last 24 months. This purchase volume represents approximately $13.05M in transactions.

Which Adial Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Adial Pharmaceuticals stock in the last 24 months: Manchester Capital Management LLC ($1.15M), and Private Advisor Group LLC ($12.75K).

How much institutional selling is happening at Adial Pharmaceuticals?

Institutional investors have sold a total of 1,167,105 shares in the last 24 months. This volume of shares sold represents approximately $3.64M in transactions.


This page (NASDAQ:ADIL) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners